Systems For Healthcare Articles & Analysis
376 news found
In this free webinar, learn about the importance of early glycan screening for ensuring biologic quality, and how automation reduces time-to-insight and improves workflow efficiency. The featured speakers will share real-world applications and results from glycan screening success. Attendees will learn how to integrate automated glycan profiling into cell line development (CLD) labs. Early ...
The medical device industry is undergoing a transformative period marked by groundbreaking innovations and advanced materials. As healthcare continues to evolve, the need for devices that enhance patient outcomes while ensuring safety and reliability is more critical than ever. Among the various materials used in medical device design, polytetrafluoroethylene (PTFE tubing) has ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that the company is joining the European Liquid Biopsy Society (ELBS), a prestigious network consisting of partners from academia and industry with the common goal of making liquid biopsy tests part of the routine standard of care. SOPHiA GENETICS offers a ...
Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. Synaptive Medical, a leader in medical technology, is set to enhance this process by evaluating its new software called Modus Plan, at Unity Health Toronto’s St. Michael’s Hospital, with support from OBIO’s Life Sciences ...
CDC warns that those most at risk of infection include patients in hospitals, especially those who: are on breathing machines have devices such as catheters have open wounds from surgery are in intensive care units “Microorganisms have always presented a challenge to healthcare providers. Miraculous science has developed various antibiotics to assist in restraining these ...
In this free webinar, learn about the challenges in maintaining reliability, reproducibility and consistency in induced pluripotent stem cell (iPSC) cultures. Attendees will be introduced to a novel cell line restoration method supported by high-throughput single-cell cloning technologies. The featured speakers will explore the different types of quality control (QC) required for iPSCs with a ...
” An estimated 435,000 PE events occur each year in the six largest European Union (EU) countries.1 Compared to the United States, the prevalence of PE is higher for those patients admitted to the emergency department in Europe, and European patients also had higher acuity and worse outcomes.2 The CE Mark for the AlphaVac F1885 System expands treatment options for ...
The data for the study came from a large public healthcare system in New York City that serves more than 1.2 million people each year. ...
Caresyntax, the leading vendor of enterprise-scale data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2023, as the company has continued its strong growth journey. Dennis Kogan, co-founder, and CEO: “Caresyntax celebrated its 10-year anniversary in 2023 and accelerated our journey of innovation and expansion ...
In this free webinar sponsored by Advanced Instruments, gain insights into advances in monoclonal antibody production technology and manufacturing strategies. Attendees will learn why temperature and osmolality in cell culture are critical parameters affecting cell growth, viability and the concentration of HCPs in the supernatant. The featured speaker will discuss how temperature and osmolality ...
As we look into the new year, the healthcare landscape in the UK is undergoing a number of changes. From digital transformation to evolving regulations, healthcare organisations across the UK are facing a number of challenges in 2024. We delve into five potential challenges confronting healthcare providers across the UK to help them prepare for the year ahead. ...
This funding will support Synaptive Medical’s $2.8 million project to expand manufacturing and research and development activities related to the company’s head-only Magnetic Resonance Imaging (MRI) system. The Synaptive MRI is a 0.5T system that was designed to overcome challenges such as accessibility in critical and acute cases like brain tumour ...
® ("TOMI") (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that the Company has entered into a contract with Vizient, Inc. increasing TO Mi's presence in the U.S. healthcare system. Vizient is the largest group purchasing organization (GPO) in the healthcare industry supplying ...
Global phase III QUASAR study will assess the efficacy and safety of aflibercept 8 mg in macular edema secondary to retinal vein occlusion (RVO) Study comes after positive data from the phase III PULSAR trial in neovascular (wet) age-related macular degeneration (nAMD) and phase II/III PHOTON trial in diabetic macular edema (DME) QUASAR is expected to enroll around 800 patients in 27 ...
ByBayer AG
Dr. Ali Tinazli's post at the Forbes magazine about "History Of Health Technologies And Meaningful Change In The Era Of Health 4.0" The medicine in ancient Egypt is some of the oldest in history. Although rudimentary, it was already highly personalized and with exclusive access. During the Renaissance—one of the most remarkable ages of humankind—medicine ...
Moreover, cellvie was chosen to compete for the prestigious Value Award, which is conferred based on the innovation's expected impact on patients and the healthcare system as a whole. While the grand prize did not go to cellvie, the Value Award did. ...
NHS Wales is a publicly funded healthcare system in Wales that provides emergency services as well as primary, secondary, specialist services, and funding for other healthcare service initiatives. ...
Airfinity has updated its cases and deaths forecast for China’s COVID-19 outbreak as the Lunar New Year holiday hastens the spread of the virus. Today’s new forecast considers reports that some provinces including Henan, Gansu, Qinghai and Yunnan have already seen infections peak. Our analytics indicators suggest that the virus has spread more quickly to rural areas, partly driven ...
XF-73 Nasal targeting peak sales potential of $1 billion in its major target markets Phase 3 patient recruitment could start in 2024 subject to completing an XF-73 Nasal partnering deal in 2023 XF-73 Nasal is the lead drug candidate developed from Destiny Pharma’s XF platform and it is initially being developed for the prevention of post-surgical staphylococcal infections, such as ...
Analysis by Airfinity shows between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity. Airfinity’s risk analysis uses cumulative peak cases and deaths from Hong Kong's BA.1 wave as a proxy for mainland China. Hong Kong took a zero-COVID approach for the first two years of the ...